Global Interventional Cardiology Devices Market, Market Analysis & Forecast 2017

The global cardiology surgical & interventional cardiology devices market is expected to grow at the CAGR of 8.5%, during forecast period 2016-2023 and reported a revenue of $48 billion in 2015.The prevalence of cardiovascular diseases around the world has increased the global cardiology surgical & interventional cardiology devices market. Change in the life style has increased the chances of cardiovascular diseases among young people too. Cardiovascular diseases (CVD) is one of the most leading cause of death globally. According to WHO Cardio vascular diseases are world’s biggest killer, WHO estimates that 17.5 million people die each year from cardiovascular diseases, accounting for around 31% of death worldwide. To reduce the loss of life due to cardiovascular diseases, several heart surgeries are being practiced. This supports the growth of the market. Raising medical tourism, global increase in healthcare spending, increasing awareness of healthy lifestyle are the key drivers primarily supporting the growth of the global cardiology surgical & interventional cardiology devices market. However, few factors such as, high cost of surgeries and stringent government policies are hindering the growth of the market.

The global increase in lifestyle oriented diseases has indirectly put pressure on the economies of the nations as the patient alone does not bear the cost of the treatment and government also provide funds for the treatment. According to Centers for Disease Control and Prevention U.S. spends more than $108.9 billion annually on cardiovascular disease prevention and treatment. Factors such as health programs, reimbursements and health insurance technological advancement, improved healthcare infrastructure, increased in RD expenditure, awareness among people related to the diseases are boosting the market growth worldwide. Global increase in life style oriented diseases & fatalities, global increase in healthcare spending, increasing awareness of healthy lifestyle to drive the market are the drivers for the market expected to increase the market in forecast years. Increase in cardio related fatalities has triggered the cardiology surgery market to grow. The most common surgeries are coronary artery bypass graft (CABG), Transmyocardial Laser Revascularization (TLR), heart valve repair and replacement, arrhythmia treatment, aneurysm repair, heart transplant, and open heart surgeries. The cases of stroke are also increasing; in the U.S alone out of 0.92 million patients 0.25 million people lose their lives due to sudden heart attack annually. Medical tourism is also one of the factor rising in the growth of the market. People from developed nations travel to low middle income countries for better and economical treatments for heart related diseases. The common destinations for medical tourism are Thailand, India, Mexico, Malaysia, Cuba, Brazil and Argentina. In India the cost of heart surgeries such as artery-clearing coronary bypass surgery cost around $1,500-$3500 while in US the cost is around $75,000 to $100,000 in the U.S. This huge difference in the cost of treatment is the reason behind the rise of medical tourism to countries that offer low cost but quality treatment.

Cardiology surgical and interventional cardiology devices market include many devices which is used for the surgery as well as for imaging diagnostic, cardiovascular stent, catheter, cardiovascular rhythm managing device. According to W.H.O. it is predicted that by 2030, 23.3 million people will be fatally affected by CVD, CHD and other heart diseases. Globally, CVD is considered to be the leading cause for all the fatalities. Increase in lifestyle oriented diseases in the emerging economies has created a demand for cardio surgeries and medical devices in these countries too. Cardiology surgical & interventional cardiology devices is one of the helpful tool in minimizing the rate of invasive surgeries with a high successful results but again the high cost to the buyers is one of the major factor restraining the growth of this market. Research centers and Hospitals are the key buyers of these devices. Thus the use of these devices are limited to the hospitals and research centers who has a lump sum capital to invest in it.

There are many future opportunities are in this market which will take the market upto next level. Increase in lifestyle oriented diseases and fatalities give an impetus to research and development so that technologically advance devices and surgical methods can be introduced in the market. Open surgeries are being mostly replaced by robotic surgeries in developed nations. Various companies, institutes and universities have been investing in research and development to come up with innovative technologies. Interventional cardiology surgeries are now more efficient due to latest techniques such as robotic surgeries and 3D virtual reality technologies. Minimally invasive surgeries enable surgeons to perform complex heart surgeries efficiently and effectively. This technological advancement has created huge scope in interventional cardiology surgeries. Minimally invasive direct coronary artery bypass surgery (MIDCAP) enables surgeons to make small incision in the concerned section of the heart. There are various other surgeries being performed through minimally invasive surgery method. Surgeries for prostate cancer, artery bypass, valve repair and replacement, arterial fibrillation, implantation of epicardial pacing wires to boost the pumping action of heart in stroke cases can be performed effectively.

High cost and adoption issues of medical devices for hospitals and clinics, reliability issues are the challenges for the market. Hospitals have issues such as high cost of surgical devices, less number of expert surgeons to fulfill demand for robotic surgeries etc. Devices offered by medical device companies are costly and the cost further increases with the addition of import tax and supply chain issues such as dependence on third party distributors and retailers. Only big and major hospitals in specific nations are equipped with robotic technologies. Latest cardiology surgeries and treatment require high level of expertise and huge capital.

The cardiology surgical and interventional cardiology devices market have various segments. CRDM (Cardiac Rhythm Disease Management) has the largest market share in terms of devices market. Cardiac catheters are growing with an impressive CAGR in overall catheters market.

Geographically the global cardiology surgical & interventional cardiology devices market is divided into North America, Europe, Asia Pacific and Rest of the World. Among all, North America is the leader of the market having maximum number of shares followed by Europe. North America is dominating market due to high prevalence of cardiovascular diseases & various technological advancements. Awareness among people related to diseases and improved healthcare infrastructure, increase in research and development expenditure, change in lifestyle are the factors boosting the market in the region. Europe is the leading market in global cardiology surgical & interventional cardiology devices market. Factors like increased cardiovascular diseases, increase in R&D funding, advanced healthcare facilities etc. enhancing the market in European region. Asia Pacific is the fastest growing market in this field due to increasing population & rapid development process, increase in cardiovascular diseases. India & China are the major contributors in APAC region & are expected to fuel this market further. Medical tourism in APAC is the key factor helping the market to increase.

Boston Scientific Corporation, C.R. Bard, Medtronic, Abbot Laboratories, St. Jude Medical, Cook Medical are the major key players of cardiology surgical & interventional cardiology devices market. Acquisitions & product launch with technological innovations are the key strategies adopted by the competitor. Such as Such as St. Jude Medical acquired Cardio MEMS in 2014. In April 18, 2017 Medtronic plc. Announced an agreement that it has entered into a definitive agreement with Cardinal Health Inc. to sell its Patient Care, Deep Vein Thrombosis, and Nutritional Insufficiency businesses within the Patient Monitoring & Recovery (PMR) division of its Minimally Invasive Therapies Group (MITG).

1. INTRODUCTION

1.1. EXECUTIVE SUMMARY

1.2. ESTIMATION METHODOLOGY

2. MARKET OVERVIEW

2.1. GLOBAL CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET: EVOLUTION & TRANSITION

2.2. MARKET DEFINITION AND SCOPE

2.3. INDUSTRY STRUCTURE

2.4. REGULATORY FRAMEWORK

2.5. TOTAL MARKET ANALYSIS

2.5.1. TOP 5 FINDINGS

2.5.2. TOP 5 OPPORTUNITY MARKETS

2.5.3. TOP 5 COMPANIES

2.5.4. TOP 3 COMPETITIVE STRATEGIES

2.6. ESTIMATION ANALYSIS

2.7. STRATEGIC ANALYSIS

2.7.1. INVESTMENT VS. ADOPTION MODEL

2.7.2. 360 DEGREE INDUSTRY ANALYSIS

2.7.3. PORTERS 5 FORCE MODEL

2.7.4. SEE-SAW ANALYSIS

2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA

2.8. COMPETITIVE ANALYSIS

2.8.1. KEY STRATEGIES AND ANALYSIS

2.8.2. MARKET SHARE

2.8.3. TOP COMPANY ANALYSIS

2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS

2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS

2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS

2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3. MARKET DETERMINANTS

3.1. MARKET DRIVERS

3.1.1. GLOBAL INCREASE IN LIFE STYLE ORIENTED DISEASES & FATALITIES

3.1.2. RAISING MEDICAL TOURISM

3.1.3. GLOBAL INCREASE IN HEALTHCARE SPENDING

3.1.4. INCREASING AWARENESS OF HEALTHY LIFESTYLE

3.2. MARKET RESTRAINTS

3.2.1. HIGH COST OF SURGERIES

3.2.2. STRINGENT GOVERNMENT POLICIES

3.3. MARKET OPPORTUNITIES

3.3.1. RESEARCH AND DEVELOPMENT TO EXPLORE HEALTHCARE ROBOTICS

3.3.2. INCREASED TECHNOLOGICAL ADVANCEMENTS IN SURGERIES

3.3.3. US FDA APPROVED MEDICAL DEVICES

3.4. MARKET CHALLENGES

3.4.1. HIGH COST AND ADOPTION ISSUES OF MEDICAL DEVICES FOR HOSPITALS AND CLINICS

3.4.2. UNSTABILITY IN PRICE OF RELIABILITY ISSUES

4. MARKET SEGMENTATION

4.1. GLOBAL CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY CARDIAC RHYTHM MANAGEMENT DEVICES

4.1.1. MARKET DEFINITION AND SCOPE

4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

4.1.4. OPPORTUNITY MATRIX

4.1.5. MARKET SEGMENTATION

4.1.5.1. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET

4.1.5.1.1. APPLICATIONS

4.1.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.5.1.4. TOP PLAYERS & KEY PRODUCTS

4.1.5.1.5. KEY CONCLUSIONS

4.1.5.2. GLOBAL ICD: CARDIOVERTER/DEFIBRILLATORS (ICD'S) MARKET

4.1.5.2.1. APPLICATIONS

4.1.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.5.2.4. TOP PLAYERS & KEY PRODUCTS

4.1.5.2.5. KEY CONCLUSIONS

4.1.5.3. GLOBAL ATRIAL FIBRILLATION MARKET

4.1.5.3.1. APPLICATIONS

4.1.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.5.3.4. TOP PLAYERS & KEY PRODUCTS

4.1.5.3.5. KEY CONCLUSIONS

4.2. GLOBAL CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY SURGERY

4.2.1. MARKET DEFINITION AND SCOPE

4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

4.2.4. OPPORTUNITY MATRIX

4.2.5. MARKET SEGMENTATION

4.2.5.1. GLOBAL CORONARY ARTERIES BYPASS GRAFTING (CABG) MARKET

4.2.5.1.1. APPLICATIONS

4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.1.4. TOP PLAYERS & KEY PRODUCTS

4.2.5.1.5. KEY CONCLUSIONS

4.2.5.2. GLOBAL ANGIOPLASTY MARKET

4.2.5.2.1. APPLICATIONS

4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.2.4. TOP PLAYERS & KEY PRODUCTS

4.2.5.2.5. KEY CONCLUSIONS

4.2.5.3. GLOBAL TRANSMYOCARDIAL LASER REVASCULARIZATION (TMR) MARKET

4.2.5.3.1. APPLICATIONS

4.2.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.3.4. TOP PLAYERS & KEY PRODUCTS

4.2.5.3.5. KEY CONCLUSIONS

4.2.5.4. GLOBAL HEART VALVE REPAIR/REPLACEMENT MARKET

4.2.5.4.1. APPLICATIONS

4.2.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.4.4. TOP PLAYERS & KEY PRODUCTS

4.2.5.4.5. KEY CONCLUSIONS

4.2.5.5. GLOBAL ARRHYTHMIA TREATMENT MARKET

4.2.5.5.1. APPLICATIONS

4.2.5.5.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.5.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.5.4. TOP PLAYERS & KEY PRODUCTS

4.2.5.5.5. KEY CONCLUSIONS

4.2.5.6. GLOBAL ANEURYSM REPAIR MARKET

4.2.5.6.1. APPLICATIONS

4.2.5.6.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.6.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.6.4. TOP PLAYERS & KEY PRODUCTS

4.2.5.6.5. KEY CONCLUSIONS

4.2.5.7. GLOBAL HEART TRANSPLANT MARKET

4.2.5.7.1. APPLICATIONS

4.2.5.7.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.7.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.7.4. TOP PLAYERS & KEY PRODUCTS

4.2.5.7.5. KEY CONCLUSIONS

4.2.5.8. GLOBAL SURGERY TO PLACE VENTRICULAR ASSIST DEVICES OR TOTAL ARTIFICIAL HEARTS MARKET

4.2.5.8.1. APPLICATIONS

4.2.5.8.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.8.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.8.4. TOP PLAYERS & KEY PRODUCTS

4.2.5.8.5. KEY CONCLUSIONS

4.2.5.9. GLOBAL OPEN HEART SURGERY MARKET

4.2.5.9.1. APPLICATIONS

4.2.5.9.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.9.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.9.4. TOP PLAYERS & KEY PRODUCTS

4.2.5.9.5. KEY CONCLUSIONS

4.2.5.10. GLOBAL OFF PUMP HEART SURGERY MARKET

4.2.5.10.1. APPLICATIONS

4.2.5.10.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.10.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.10.4. TOP PLAYERS & KEY PRODUCTS

4.2.5.10.5. KEY CONCLUSIONS

4.2.5.11. GLOBAL MINIMALLY INVASIVE SURGERIES MARKET

4.2.5.11.1. APPLICATIONS

4.2.5.11.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.11.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.11.4. TOP PLAYERS & KEY PRODUCTS

4.2.5.11.5. KEY CONCLUSIONS

4.3. GLOBAL CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY IMAGING DEVICES

4.3.1. MARKET DEFINITION AND SCOPE

4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

4.3.4. OPPORTUNITY MATRIX

4.3.5. MARKET SEGMENTATION

4.3.5.1. GLOBAL IMAGING DEVICES MARKET

4.3.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS

4.3.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.3.5.1.3. TOP PLAYERS & KEY PRODUCTS

4.3.5.1.4. KEY CONCLUSIONS

4.3.5.2. GLOBAL REAL TIME IMAGING MARKET

4.3.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS

4.3.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.3.5.2.3. TOP PLAYERS & KEY PRODUCTS

4.3.5.2.4. KEY CONCLUSIONS

4.3.5.3. GLOBAL MAGNETIC RESONANCE ANGIOGRAM (MRA) MARKET

4.3.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS

4.3.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.3.5.3.3. TOP PLAYERS & KEY PRODUCTS

4.3.5.3.4. KEY CONCLUSIONS

4.3.5.4. GLOBAL FLUOROSCOPY MARKET

4.3.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS

4.3.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.3.5.4.3. TOP PLAYERS & KEY PRODUCTS

4.3.5.4.4. KEY CONCLUSIONS

4.3.5.5. GLOBAL ECHOCARDIOGRAPHY MARKET

4.3.5.5.1. ADOPTION SCENARIO & MARKET DETERMINANTS

4.3.5.5.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.3.5.5.3. TOP PLAYERS & KEY PRODUCTS

4.3.5.5.4. KEY CONCLUSIONS

4.4. GLOBAL CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY CARDIAC CATHETERIZATION

4.4.1. MARKET DEFINITION AND SCOPE

4.4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

4.4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

4.4.4. OPPORTUNITY MATRIX

4.4.5. MARKET SEGMENTATION

5. COMPETITIVE LANDSCAPE

5.1. KEY STRATEGIES

5.1.1. LIST OF MERGERS & ACQUISITION

5.1.2. LIST OF JOINT VENTURES

5.1.3. LIST OF PRODUCT LAUNCH

5.1.4. LIST OF PARTNERSHIPS

5.2. TOP 10 COMPANY ANALYSIS

6. GLOBAL CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY REGION

6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

6.3. OPPORTUNITY MATRIX

6.4. GEOGRAPHIC SEGMENTATION

6.4.1. NORTH AMERICA

6.4.1.1. INDUSTRY APPLICATION ANALYSIS

6.4.1.2. TOP COUNTRY ANALYSIS

6.4.1.2.1. U.S.

6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.1.2.1.2. TOP PLAYERS & KEY PRODUCTS

6.4.1.2.1.3. KEY CONCLUSIONS

6.4.1.2.2. CANADA

6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.1.2.2.2. TOP PLAYERS & KEY PRODUCTS

6.4.1.2.2.3. KEY CONCLUSIONS

6.4.2. EUROPE

6.4.2.1. INDUSTRY APPLICATION ANALYSIS

6.4.2.2. TOP COUNTRY ANALYSIS

6.4.2.2.1. UK

6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.2.2.1.2. TOP PLAYERS & KEY PRODUCTS

6.4.2.2.1.3. KEY CONCLUSIONS

6.4.2.2.2. FRANCE

6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.2.2.2.2. TOP PLAYERS & KEY PRODUCTS

6.4.2.2.2.3. KEY CONCLUSIONS

6.4.2.2.3. ITALY

6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.2.2.3.2. TOP PLAYERS & KEY PRODUCTS

6.4.2.2.3.3. KEY CONCLUSIONS

6.4.2.2.4. SPAIN

6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.2.2.4.2. TOP PLAYERS & KEY PRODUCTS

6.4.2.2.4.3. KEY CONCLUSIONS

6.4.2.2.5. REST OF EUROPE

6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.2.2.5.2. TOP PLAYERS & KEY PRODUCTS

6.4.2.2.5.3. KEY CONCLUSIONS

6.4.3. ASIA PACIFIC

6.4.3.1. INDUSTRY APPLICATION ANALYSIS

6.4.3.2. TOP COUNTRY ANALYSIS

6.4.3.2.1. CHINA

6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.3.2.1.2. TOP PLAYERS & KEY PRODUCTS

6.4.3.2.1.3. KEY CONCLUSIONS

6.4.3.2.2. INDIA

6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.3.2.2.2. TOP PLAYERS & KEY PRODUCTS

6.4.3.2.2.3. KEY CONCLUSIONS

6.4.3.2.3. JAPAN

6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.3.2.3.2. TOP PLAYERS & KEY PRODUCTS

6.4.3.2.3.3. KEY CONCLUSIONS

6.4.3.2.4. SOUTH KOREA

6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.3.2.4.2. TOP PLAYERS & KEY PRODUCTS

6.4.3.2.4.3. KEY CONCLUSIONS

6.4.3.2.5. REST OF ASIA PACIFIC

6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.3.2.5.2. TOP PLAYERS & KEY PRODUCTS

6.4.3.2.5.3. KEY CONCLUSIONS

6.4.4. ROW

6.4.4.1. INDUSTRY APPLICATION ANALYSIS

6.4.4.2. TOP COUNTRY ANALYSIS

6.4.4.2.1. LATIN AMERICA

6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.4.2.1.2. TOP PLAYERS & KEY PRODUCTS

6.4.4.2.1.3. KEY CONCLUSIONS

6.4.4.2.2. MIDDLE EAST & AFRICA

6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.4.2.2.2. TOP PLAYERS & KEY PRODUCTS

6.4.4.2.2.3. KEY CONCLUSIONS

7. COMPANY PROFILES

7.1. BOSTON SCIENTIFIC CORPORATION

7.1.1. OVERVIEW

7.1.2. PRODUCT PORTFOLIO

7.1.3. KEY INNOVATION SECTOR

7.1.4. STRATEGIC INITIATIVES

7.1.5. SCOT ANALYSIS

7.1.6. STRATEGIC ANALYSIS

7.2. C.R. BARD

7.2.1. OVERVIEW

7.2.2. PRODUCT PORTFOLIO

7.2.3. KEY INNOVATION SECTOR

7.2.4. STRATEGIC INITIATIVES

7.2.5. SCOT ANALYSIS

7.2.6. STRATEGIC ANALYSIS

7.3. ABBOT LABORATORIES.

7.3.1. OVERVIEW

7.3.2. PRODUCT PORTFOLIO

7.3.3. KEY INNOVATION SECTOR

7.3.4. STRATEGIC INITIATIVES

7.3.5. SCOT ANALYSIS

7.3.6. STRATEGIC ANALYSIS

7.4. JUDE MEDICAL

7.4.1. OVERVIEW

7.4.2. PRODUCT PORTFOLIO

7.4.3. KEY INNOVATION SECTOR

7.4.4. STRATEGIC INITIATIVES

7.4.5. SCOT ANALYSIS

7.4.6. STRATEGIC ANALYSIS

7.5. COOK MEDICAL OVERVIEW

7.5.1. PRODUCT PORTFOLIO

7.5.2. KEY INNOVATION SECTOR

7.5.3. STRATEGIC INITIATIVES

7.5.4. SCOT ANALYSIS

7.5.5. STRATEGIC ANALYSIS

7.6. BIOSENSE WEBSTER

7.6.1. OVERVIEW

7.6.2. PRODUCT PORTFOLIO

7.6.3. KEY INNOVATION SECTOR

7.6.4. STRATEGIC INITIATIVES

7.6.5. SCOT ANALYSIS

7.6.6. STRATEGIC ANALYSIS

7.7. EDWARDS LIFESCIENCE

7.7.1. OVERVIEW

7.7.2. PRODUCT PORTFOLIO

7.7.3. KEY INNOVATION SECTOR

7.7.4. STRATEGIC INITIATIVES

7.7.5. SCOT ANALYSIS

7.7.6. STRATEGIC ANALYSIS

7.8. LOMBARD MEDICAL

7.8.1. OVERVIEW

7.8.2. PRODUCT PORTFOLIO

7.8.3. KEY INNOVATION SECTOR

7.8.4. STRATEGIC INITIATIVES

7.8.5. SCOT ANALYSIS

7.8.6. STRATEGIC ANALYSIS

7.9. ATRIUM MEDICAL CORPORATION

7.9.1. OVERVIEW

7.9.2. PRODUCT PORTFOLIO

7.9.3. KEY INNOVATION SECTOR

7.9.4. STRATEGIC INITIATIVES

7.9.5. SCOT ANALYSIS

7.9.6. STRATEGIC ANALYSIS

7.10. HANSEN MEDICAL

7.10.1. OVERVIEW

7.10.2. PRODUCT PORTFOLIO

7.10.3. KEY INNOVATION SECTOR

7.10.4. STRATEGIC INITIATIVES

7.10.5. SCOT ANALYSIS

7.10.6. STRATEGIC ANALYSIS

7.11. GE HEALTHCARE

7.11.1. OVERVIEW

7.11.2. PRODUCT PORTFOLIO

7.11.3. KEY INNOVATION SECTOR

7.11.4. STRATEGIC INITIATIVES

7.11.5. SCOT ANALYSIS

7.11.6. STRATEGIC ANALYSIS

7.12. PHILIPS HEALTHCARE

7.12.1. OVERVIEW

7.12.2. PRODUCT PORTFOLIO

7.12.3. KEY INNOVATION SECTOR

7.12.4. STRATEGIC INITIATIVES

7.12.5. SCOT ANALYSIS

7.12.6. STRATEGIC ANALYSIS

7.13. SMITH MEDICAL

7.13.1. OVERVIEW

7.13.2. PRODUCT PORTFOLIO

7.13.3. KEY INNOVATION SECTOR

7.13.4. STRATEGIC INITIATIVES

7.13.5. SCOT ANALYSIS

7.13.6. STRATEGIC ANALYSIS

7.14. BERLIN HEART

7.14.1. OVERVIEW

7.14.2. PRODUCT PORTFOLIO

7.14.3. KEY INNOVATION SECTOR

7.14.4. STRATEGIC INITIATIVES

7.14.5. SCOT ANALYSIS

7.14.6. STRATEGIC ANALYSIS

7.15. CAMBRIDGE HEART, INC.

7.15.1. OVERVIEW

7.15.2. PRODUCT PORTFOLIO

7.15.3. KEY INNOVATION SECTOR

7.15.4. STRATEGIC INITIATIVES

7.15.5. SCOT ANALYSIS

7.15.6. STRATEGIC ANALYSIS

LIST OF TABLES

1. GLOBAL CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY CARDIAC RHYTHM MANAGEMENT 2014-2023 ($ MILLION)

2. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

3. GLOBAL ICD: CARDIOVERTER/DEFIBRILLATORS (ICD'S) CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

4. GLOBAL ATRIAL FIBRILLATION CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

5. GLOBAL CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY SURGERY 2014-2023 ($ MILLION)

6. GLOBAL CORONARY ARTERIES BYPASS GRAFTING (CABG) CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

7. GLOBAL ANGIOPLASTY CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

8. GLOBAL TRANSMYOCARDIAL LASER REVASCULARIZATION (TMR) CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

9. GLOBAL HEART VALVE REPAIR/REPLACEMENT CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

10. GLOBAL ARRHYTHMIA TREATMENT CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

11. GLOBAL ANEURYSM REPAIR CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

12. GLOBAL HEART TRANSPLANT CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

13. GLOBAL SURGERY TO PLACE VENTRICULAR ASSIST DEVICES OR TOTAL ARTIFICIAL HEARTS CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

14. GLOBAL OPEN HEART SURGERY CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

15. GLOBAL OFF PUMP HEART SURGERY CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

16. GLOBAL MINIMALLY INVASIVE SURGERIES CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

17. GLOBAL CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY IMAGING DEVICES 2014-2023 ($ MILLION)

18. GLOBAL IMAGING DEVICES CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

19. GLOBAL REAL TIME IMAGING CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

20. GLOBAL MAGNETIC RESONANCE ANGIOGRAM (MRA) CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

21. GLOBAL FLUOROSCOPY CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

22. GLOBAL ECHOCARDIOGRAPHY CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

23. GLOBAL CARDIAC CATHETERIZATION CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY SOURCE 2014-2023 ($ MILLION)

24. NORTH AMERICA CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET 2014-2023 ($ MILLION)

25. EUROPE CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET 2014-2023 ($ MILLION)

26. ASIA PACIFIC CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET 2014-2023 ($ MILLION)

27. REST OF THE WORLD CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET 2014-2023 ($ MILLION)

LIST OF FIGURES

1. GLOBAL CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY CARDIAC RHYTHM MANAGEMENT DEVICES MARKET 2014-2023 ($ MILLION)

2. GLOBAL CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY ICD: CARDIOVERTER/DEFIBRILLATORS (ICD'S)MARKET 2014-2023 ($ MILLION)

3. GLOBAL CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY ATRIAL FIBRILLATION MARKET 2014-2023 ($ MILLION)

4. GLOBAL CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY CORONARY ARTERIES BYPASS GRAFTING (CABG) MARKET 2014-2023 ($ MILLION)

5. GLOBAL CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY ANGIOPLASTY MARKET 2014-2023 ($ MILLION)

6. GLOBAL CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY TRANSMYOCARDIAL LASER REVASCULARIZATION (TMR) MARKET 2014-2023 ($ MILLION)

7. GLOBAL CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY HEART VALVE REPAIR/REPLACEMENT 2014-2023 ($ MILLION)

8. GLOBAL CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY ARRHYTHMIA TREATMENT MARKET 2014-2023 ($ MILLION)

9. GLOBAL CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY ANEURYSM REPAIR 2014-2023 ($ MILLION)

10. GLOBAL CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY HEART TRANSPLANT MARKET 2014-2023 ($ MILLION)

11. GLOBAL CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY SURGERY TO PLACE VENTRICULAR ASSIST DEVICES OR TOTAL ARTIFICIAL HEARTS MARKET 2014-2023 ($ MILLION)

12. GLOBAL CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY OPEN HEART SURGERY MARKET 2014-2023 ($ MILLION)

13. GLOBAL CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY OFF PUMP HEART SURGERY MARKET 2014-2023 ($ MILLION)

14. GLOBAL CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY MINIMALLY INVASIVE SURGERIES MARKET 2014-2023 ($ MILLION)

15. GLOBAL CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY IMAGING DEVICES MARKET 2014-2023 ($ MILLION)

16. GLOBAL CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY REAL TIME IMAGING MARKET2014-2023 ($ MILLION)

17. GLOBAL CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY MAGNETIC RESONANCE ANGIOGRAM (MRA) MARKET 2014-2023 ($ MILLION)

18. GLOBAL CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY FLUOROSCOPY MARKET 2014-2023 ($ MILLION)

19. GLOBAL CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET BY ECHOCARDIOGRAPHY MARKET 2014-2023 ($ MILLION)

20. UNITED STATES (U.S.) CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET 2014-2023 ($ MILLION)

21. CANADA CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET 2014-2023 ($ MILLION)

22. UNITED KINGDOM (UK) CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET2014-2023 ($ MILLION)

23. FRANCE CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET 2014-2023 ($ MILLION)

24. GERMANY CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET 2014-2023 ($ MILLION)

25. ITALY CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET 2014-2023 ($ MILLION)

26. SPAIN CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET 2014-2023 ($ MILLION)

27. ROE CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET 2014-2023 ($ MILLION)

28. INDIA CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET 2014-2023 ($ MILLION)

29. CHINA CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET 2014-2023 ($ MILLION)

30. JAPAN CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET 2014-2023 ($ MILLION)

31. KOREA CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET 2014-2023 ($ MILLION)

32. ROW APAC CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET 2014-2023 ($ MILLION)

33. LATIN AMERICA CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET 2014-2023 ($ MILLION)

34. MENA CARDIOLOGY SURGICAL & INTERVENTIONAL CARDIOLOGY DEVICES MARKET 2014-2023 ($ MILLION)

Login

Forgot Password

Thank you for your request!

Thank you for downloading..!

Global Cardiology Surgical & Interventional Cardiology Devices Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023

FAQ

Request for Sample

UPCOMING REPORTS

NAVIGATION LINK

OUR SERVICES

CONNECT WITH US